Is APLT or XYLD a better dividend investment in 2026?

APLT currently yields 1941.75% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: APLT offers higher current income.

What is the dividend yield difference between APLT and XYLD?

APLT has a forward dividend yield of 1941.75% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 1930.77 percentage points.

Home › Compare › APLT vs XYLD

APLT vs XYLD: Dividend Comparison 2026

APLT yields 1941.75% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 APLT wins by $7549549081.31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

APLT

● Live price

1941.75%

Share price

$0.10

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7549549081.34M

Annual income

$6,855,073,294,458,854.00

Full APLT calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — APLT vs XYLD

📍 APLT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	APLT	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, APLT + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

APLT pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APLT

Annual income on $10K today (after 15% tax)

$165,048.54/yr

After 10yr DRIP, annual income (after tax)

$5,826,812,300,290,026.00/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, APLT beats the other by $5,826,812,300,287,290.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APLT + XYLD for your $10,000?

APLT: 50%XYLD: 50%

100% XYLD50/50100% APLT

Portfolio after 10yr

$3774774540.68M

Annual income

$3,427,536,647,231,036.50/yr

Blended yield

90.80%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APLT buys

XYLD buys

No recent congressional trades found for APLT or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAPLTXYLD

Forward yield	1941.75% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$7549549081.34M ✓	$25.3K
Annual income after 10y	$6,855,073,294,458,854.00 ✓	$3,219.02
Total dividends collected	$7500143229.39M ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: APLT vs XYLD ($10,000, DRIP)

Year	APLT Portfolio	APLT Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$204,875	$194,174.76	$10,818	$1,098.39	+$194.1K → APLT
2	$3,937,114	$3,717,897.78	$11,738	$1,222.51	+$3.93M → APLT
3	$70,986,064	$66,773,352.36	$12,774	$1,364.64	+$70.97M → APLT
4	$1,201,115,737	$1,125,160,648.71	$13,944	$1,527.86	+$1201.10M → APLT
5	$19,077,920,928	$17,792,727,089.23	$15,270	$1,715.87	+$19077.91M → APLT
6	$284,535,588,112	$264,122,212,719.20	$16,775	$1,933.09	+$284535.57M → APLT
7	$3,985,969,128,556	$3,681,516,049,275.53	$18,490	$2,184.87	+$3985969.11M → APLT
8	$52,464,234,462,079	$48,199,247,494,524.41	$20,450	$2,477.63	+$52464234.44M → APLT
9	$649,042,791,475,683	$592,906,060,601,258.60	$22,697	$2,819.19	+$649042791.45M → APLT
10	$7,549,549,081,337,835	$6,855,073,294,458,854.00	$25,280	$3,219.02	+$7549549081.31M → APLT

APLT vs XYLD: Complete Analysis 2026

APLT — Stock

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Full APLT Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this APLT vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APLT vs SCHD APLT vs JEPI APLT vs O APLT vs KO APLT vs MAIN APLT vs QYLD APLT vs JEPQ APLT vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.